Researchers in New Delhi have developed a disposable paper-based electrochemical sensor that simultaneously detects Alzheimer ...

The U.S. Biomarker Testing Market is estimated to be worth USD 11.67 billion in 2025 and is projected to increase at a compound annual growth rate (CAGR) of 2.25% from 2026 to 2035, reaching USD 14.57 ...

In advanced non–small cell lung cancer (NSCLC), molecular testing must be completed in time to guide first-line treatment. Broad molecular profiling is recommended for advanced nonsquamous NSCLC and, ...

New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA, Mass.--(BUSINESS WIRE)--Lucent ...

Biomarker profiles are tumor-specific and can predict sensitivity or resistance to targeted therapy or immune checkpoint inhibition, enabling more individualized treatment selection than histology ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Please provide your email address to receive an email when new articles are posted on . Time from biopsy to receipt of molecular testing results decreased, but most of the improvement occurred at the ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

—A new study of more than 42,000 patients sought to evaluate contemporary trends in testing for biomarkers of non-small cell lung cancer (NSCLC), as well as rates of treatment with ...

Every year, America’s medical research pipeline produces new treatments, new technologies and new ways to improve patient care. Often, the real challenge is ensuring policy keeps pace with these ...

Please provide your email address to receive an email when new articles are posted on . Biomarker testing appeared inconsistent, with rates not reflecting guidelines. Less than 25% of oncologists ...